Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019–2023 compared to 2003–2008
Authors:
- 4 October 2023
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (12) , 1649-1652
Abstract
The prevalence of different HPV types, especially HPV16 and 18 in cervical cancer in patients diagnosed 2019-2023 in Stockholm was compared to corresponding data from 2003-2008 before the introduction of HPV vaccination in Sweden. Cervical cancer samples from 125 patients diagnosed 2019-2023 in Stockholm were analysed for 27 HPV types by multiplex assay and the HPV type prevalence data was compared to data obtained in 154 cervical samples from 2003-2008. Patient median age was higher 2019-2023 compared to 2003-2008 (55-years vs. 42-years, p = 0.046). Overall HPV prevalence was 93.6%, HPV16 and 18 accounted for 62.2% of all squamous cell carcinoma cases (SCC) and 63.6% of all adenocarcinoma cases (ADC) vs. 92.9%, 69.7% and 88.6% respectively 2003-2008. The joint prevalence of HPV16 and 18 in SCC and ADC tended to be slightly lower in 2019-2023 as compared to 2003-2008, but the difference was not statistically significant.Keywords
Funding Information
- Karolinska Institutet
- The Swedish Childhood Foundation
- The Swedish City Council
This publication has 13 references indexed in Scilit:
- Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group StudyGynecologic Oncology, 2019
- New prophylactics human papilloma virus (HPV) vaccines against cervical cancerJournal of Obstetrics and Gynaecology, 2018
- Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline dataVaccine, 2018
- Uterine cervix cancer treatment at Radiumhemmet: 90 years' experience. Time trends of age, stage, and histopathology distributionCancer Medicine, 2014
- Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccinationActa Oncologica, 2011
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in EnglandBritish Journal of Cancer, 2010
- NORDCAN – a Nordic tool for cancer information, planning, quality control and researchActa Oncologica, 2010
- Human Papillomavirus Types in Invasive Cervical Cancer Specimens From TurkeyInternational Journal of Gynecological Pathology, 2009
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002